MusclePharm (MSLP) Stock Price, News & Analysis

Company Overview

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 26,442 shs
• Market Capitalization: $7,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MSLP Stock Analysis - Frequently Asked Questions

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) announced its earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.32. The company earned $50.48 million during the quarter, compared to analysts' expectations of $55 million.

How do I buy shares of MusclePharm?

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF) and Humacyte (HUMA).

Company Calendar

• Last Earnings: 8/10/2015
• Today: 5/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:MSLP
• CIK: 1415684
• Web: www.musclepharm.com
• Phone: (800) 292-3909
• Fax: N/A
• Employees: 20
• Year Founded: 2008

Profitability

• EPS (Most Recent Fiscal Year): ($0.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-12,870,000.00
• Net Margins: -38.51%
• Pretax Margin: -38.52%
• Return on Equity: N/A
• Return on Assets: -169.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.25
• Quick Ratio: 0.23

Sales & Book Value

• Annual Sales: $50.04 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.94) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,390,000
• Free Float: 13,121,000
• Market Cap: $7,000.00
• Optionable: Not Optionable
• Beta: -0.07